Gene Therapy Gets FDA's Strongest Warning After Fatal Liver Injuries

(MedPage Today) — The FDA added a boxed warning to delandistrogen moxeparvovec (Elevidys) gene therapy for Duchenne muscular dystrophy and changed the drug’s indication after reports of fatal liver damage emerged, the agency announced Friday…